[PREVENCAT study: control of cardiovascular risk in primary care]

Luis A Alvarez-Sala1, Carmen Suárez, Teresa Mantilla

  • 1Departamento de Medicina, Hospital General Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, Spain.

Medicina Clinica
|April 1, 2005
PubMed

Insights

Cardiovascular risk factor control is insufficient in primary care patients with hypertension, diabetes, and hypercholesterolemia. Metabolic syndrome affects half of these patients, highlighting a critical public health concern.

Area of Science:

  • Cardiology
  • Primary Care Medicine
  • Public Health

Background:

  • Cardiovascular risk factors (CVRF) are often studied individually.
  • The PREVENCAT study addresses CVRF control in patients with hypertension (HT), type 2 diabetes mellitus (DM2), and/or hypercholesterolemia (HC) in primary care.

Purpose of the Study:

  • To estimate the control of CVRF in primary care patients with HT, DM2, and/or HC.
  • To assess the prevalence of Metabolic Syndrome (MS) in this patient group.

Main Methods:

  • A multicenter, cross-sectional study involving primary care physicians in Spain.
  • Recruitment of patients diagnosed with HT, DM2, and/or HC.
  • Assessment of blood pressure, cholesterol, glycaemia, obesity, smoking status, and physical activity.

Main Results:

  • 2,649 patients were recruited; 51.6% were women, with a mean age of 64 years.
  • Hypertension was the most frequent diagnosis (78.9%), followed by hypercholesterolemia (58.4%) and DM2 (37.4%).
  • Control rates were suboptimal: 40.0% for blood pressure, 42.6% for cholesterol, and 62.7% for basal glycaemia. Only 15.6% had a healthy BMI, 46.2% practiced regular physical activity, and 87.5% were non-smokers. The prevalence of metabolic syndrome was 50.6%.

Conclusions:

  • Cardiovascular risk factor control in primary care is inadequate.
  • Less than half of patients with HT, DM2, and HC are effectively managed.
  • Overweight and sedentary lifestyles present significant challenges in this population.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...